Literature DB >> 880376

[Erythropoiesis in iron deficiency].

P Dörmer, B Lau.   

Abstract

The kinetics of erythroblast proliferation were studied by means of quantitative 14C-autoradiography in 5 patients showing anemia due to infection or malignancy, in 7 patients suffering from iron deficiency anemia, and in two individuals with bleeding enemia. Compared with a group of 5 healthy persons a markedly reduced turnover of erythroblasts was found in the anemia due to infection, malignancy, and iron deficiency, whereas this turnover was normal or increased in the case of bleeding anemia. The reduction is caused by a progressively decreasing rate of erythroblast proliferation and maturation with advancing development into mature cells. No indications of a change in the number of cell divisions were found in the anemia of infection, malignancy, and of iron deficiency, nor was there evidence of an intramedullary death of nucleated red cell percursors. The imbalance between production and loss of red cells causing anemia shows a different pattern in the 3 groups of disease: In bleeding anemia the insufficiency of supply is not yet apparent from the rate of erythroblast turnover giving weight to the factor of blood loss. In anemia due to infection, malignancy, and iron deficiency the but moderately increased rate of red cell destruction cannot be compensated because of several impairments: The rate of erythroblast turnover is reduced, and, in addition, a moderate portion of maturing cells is destroyed, probably at the reticulocyte stage. As the most significant factor, the bone marrow is unable to compensate the anemia by an effective erythroblast hyperplasia. In iron deficiency this hyperplasia is inadequately low, in infection and malignancies, however, it is more or less missing.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 880376     DOI: 10.1007/bf00996872

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  25 in total

1.  Mitotic indices of human bone marrow cells. II. The use of mitotic indices for estimation of time parameters of proliferation in serially connected multiplicative cellular compartments.

Authors:  S A KILLMANN; E P CRONKITE; T M FLIEDNER; V P BOND; G BRECHER
Journal:  Blood       Date:  1963-02       Impact factor: 22.113

2.  The natural history of iron deficiency induced by phlebotomy.

Authors:  M E CONRAD; W H CROSBY
Journal:  Blood       Date:  1962-08       Impact factor: 22.113

3.  Methods of quantitative autoradiography using incident light microphotometry.

Authors:  P Dörmer; E Thiel
Journal:  J Histochem Cytochem       Date:  1976-01       Impact factor: 2.479

4.  Iron deficiency: impaired liver growth and DNA synthesis in the rat.

Authors:  M A Siimes; P R Dallman
Journal:  Br J Haematol       Date:  1974-12       Impact factor: 6.998

Review 5.  Ferrokinetics in man.

Authors:  C A Finch; K Deubelbeiss; J D Cook; J W Eschbach; L A Harker; D D Funk; G Marsaglia; R S Hillman; S Slichter; J W Adamson; A Ganzoni; E R Biblett
Journal:  Medicine (Baltimore)       Date:  1970-01       Impact factor: 1.889

6.  Control of erythropoiesis in rats with adjuvant-induced chronic inflammation.

Authors:  J N Lukens
Journal:  Blood       Date:  1973-01       Impact factor: 22.113

7.  [Model for erythropoiesis obtained from H3 thymidine uptake by the marrow "in vitro" and confirmed by ferro-kinetic studies "in vivo". I. Results obtained in normal subjects].

Authors:  Y Najean; J Donio; C Dresch
Journal:  Rev Fr Etud Clin Biol       Date:  1969 Jun-Jul

8.  Regulation of erythropoiesis. XX. Kinetics of red cell production.

Authors:  F Stohlman; S Ebbe; B Morse; D Howard; J Donovan
Journal:  Ann N Y Acad Sci       Date:  1968-03-29       Impact factor: 5.691

9.  Effect of iron deficiency and desferrioxamine on DNA synthesis in human cells.

Authors:  A V Hoffbrand; K Ganeshaguru; J W Hooton; M H Tattersall
Journal:  Br J Haematol       Date:  1976-08       Impact factor: 6.998

10.  Bone marrow erythropoiesis in the anemia of infection, inflammation, and malignancy.

Authors:  S Zucker; S Friedman; R M Lysik
Journal:  J Clin Invest       Date:  1974-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.